Loading...
StocksRunner logo
 
 
Ardelyx
3.91
-0.51%
 
ARDX Ardelyx
Last Price
Change
3.91
 
-0.51%
 
 
 

 
Sentiment
 
 

4.65

4.05

3.07

0.57

 
 
1m
3m
6m
1y
 

Summary

  Login to display Ardelyx (ARDX) recommendation from the last 90 days from financial news and social media.
 

Strengths

Rewards

 Trading below its fair value

Rewards

 Outperform the market

 
 

Risk Level

 
StocksRunner
 

Ardelyx (ARDX) has High Risk Level

Click here to check what is your level of risk

 

Analysts Opinion

Click on the category for more information
 
 

Earnings

×
 

Earnings

2.67
 

StocksRunner

 Reported a weak earnings

 
 

Rating

×
 

Rating

5.00
 
 

Momentum

×
 

Momentum

4.00
 
 

Activity

×
 

Activity

4.00
 
 

Future

×
 

Future

4.50
 

StocksRunner

 Trading below its fair value

StocksRunner

 Outperform the market

 
 

Analysts Opinion

Analysts opinion is negative and it remained unchanged from the past 3 months

 

Street Consensus

Buy
Opinion
Trend
Score
Potential
Score
 
80%
100%
100%
100%
 
On Track
On Track
On Track
 

Street Opinion 

Street view is extremely ish and have positive views on the near-term outlook

 
Events Rating
 
Very Bullish
Bullish
Neutral
Bearish
Very Bearish
 
Positive vs Negative
 
80%
20%
Positive
Negative
8 out of 10
events present
2 out of 10
events present
 

 
Events Calendar
Click for more information
 
May
S
M
T
W
T
F
S
June
S
M
T
W
T
F
S
 
Highlights
Last
Modify
Closing
Price
%
Change

 
Options Activity
2 Month Ago
4.70
+0.43%
 
Weak Earnings
2 Month Ago
4.67
+5.07%
 
Top Headlines

ardelyxs tenapanor nda resubmission accepted by fda.

Wed May 17, 2023

Activity

unusual call option trade in ardelyx (ardx) worth $75.00k. on may 3 2023 at 13:05:15 et an unusually large $75.00k block of call contracts in ardelyx (ardx) was sold with a strike price of $3.50 / share expiring in 79 day(s) (on july 21 2023).

Thu May 4, 2023

Momentum

ardelyx (ardx) reports q1 loss tops revenue estimates. ardelyx (ardx) came out with a quarterly loss of $0.13 per share versus the zacks consensus estimate of a loss of $0.11. this compares to loss of $0.21 per share a year ago. these

Wed May 3, 2023

Earnings
Earnings

ardelyx gaap eps of -$0.13 misses by $0.03 revenue of $11.4m beats by $0.99m.

Wed May 3, 2023

Earnings

ardelyx: underappreciated biotech with potential fda approval on deck.

Mon Apr 24, 2023

Activity
Potential

ardelyx resubmits nda to fda for xphozah. (rttnews) - ardelyx inc. (ardx) said that it resubmitted a new drug application or nda to the United States food and drug administration for the approval of xphozah (tenapanor) for the control of serum p

Tue Apr 18, 2023

Activity

wedbush maintains ardelyx (ardx) outperform recommendation. fintel reports that on april 17 2023 wedbush maintained coverage of ardelyx (nasdaq:ardx) with a outperform recommendation.

Mon Apr 17, 2023

Potential

 
 
 
StocksRunner

Get all the pieces of the puzzle on important data activity before the major news sources break the story and find out what happening right now and what could happen in the future

FIND US ON

StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss
 

Receive our daily ARDX alerts

Enter your email to receive daily alerts

 
Home

Leading Gainers

Upgrades

Downgrades

Top Leaders

 
Categories

Ipo's

Dividend

Option Activity

Insiders Activity

Institutional Holdings

 
Tags

New Products

FDA Approvals

Agreements

Financial Reports

 
About Us

Log In

Sign Up

Contact Us

Terms of use

Privacy Policy

 
 

Disclaimer: The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

 
StocksRunner

StocksRunner

Get the pulse of the market

 
StocksRunner

ARDX Ardelyx

Last Price
3.91
Change
-0.51%
 
 

Summary

  Login to display Ardelyx (ARDX) recommendation from the last 90 days from financial news and social media.

 
 
4.65
4.05
3.07
0.57
 
 
1m
3m
6m
1y
 
Sentiment

Strengths

Rewards

 Trading below its fair value

Rewards

 Outperform the market

 
 
 
 
Street Consensus
 
Buy
Opinion
Trend
Score
Potential
Score
 
100%
100%
100%
On Track
On Track
On Track
 
80%
20%
Positive
Negative
8 out of 10
events present
2 out of 10
events present
 

Street Opinion

Street view is extremely ish and have positive views on the near-term outlook

 
 
Analysts Opinion
Hover the category for more information
 
 

Earnings

×
 

Earnings

2.67
 

StocksRunner

 Reported a weak earnings

 
 

Rating

×
 

Rating

5.00
 
 

Momentum

×
 

Momentum

4.00
 
 

Activity

×
 

Activity

4.00
 
 

Future

×
 

Future

4.50
 

StocksRunner

 Trading below its fair value

StocksRunner

 Outperform the market

 
 

Analysts Opinion

Analysts opinion is negative and it remained unchanged from the past 3 months

 
 
 
 
 
Events Rating
 
Very Bullish
Bullish
Neutral
Bearish
Very Bearish
 
 
Risk Level
 
StocksRunner
 

Ardelyx (ARDX) has High Risk Level.  Click here to check what is your level of risk

 
 
 

Events Calendar

Hover for information

 
May
 
S
M
T
W
T
F
S
 
June
 
S
M
T
W
T
F
S
 
 
 
 
Highlights
Last
Modify
Closing
Price
%
Change

 
Options Activity
2 Month Ago
4.70
+0.43%
 
Weak Earnings
2 Month Ago
4.67
+5.07%
 
 
 
StocksRunner

Get all the pieces of the puzzle on important data activity before the major news sources break the story and find out what happening right now and what could happen in the future

FIND US ON

StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss

 

Receive our daily ARDX Alerts

Enter your email to receive daily alerts

 
Home

Leading Gainers

Upgrades

Downgrades

Top Leaders

Categories

Ipo's

Dividend

Option Activity

Insiders Activity

Institutional Holdings

Tags

New Products

FDA Approvals

Agreements

Financial Reports

 
 

Disclaimer: The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

 
 
 
 
 

Top Headlines